Anthem Biosciences files DRHP for Rs 3,395 crore IPO
Anthem, whose services include early-stage drug discovery and drug efficacy testing, said private equity firm True North and drugmaker DavosPharma are among investors who will sell shares in the IPO.
The company will not sell any shares and it did not give any other details on the offering.
The offer for sale (OFS) comprises promoter shareholders Ganesh Sambasivam and K Ravindra Chandrappa selling equity shares aggregating up to Rs. 350 crores each. Viridity Tone LLP (True North) will be selling Equity Shares aggregating up to Rs. 1,325 crores and Rs. 320 crores by Portsmouth Technologies LLC
The other shareholders selling include up to Rs. 320 crores each by Malay J Barua, Rupesh N Kinekar, Satish Sharma, up to Rs. 80 crores by Prakash Kariabettan and up to Rs. 10 crores by K Ramakrishnan.
Stock Trading
Masterclass on Value Investing and Company Valuation
By — The Economic Times, Get Certified By India's Top Business News Brand
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock Trading
Technical Analysis for Everyone — Technical Analysis Course
By — Abhijit Paul, Technical Research Head, Fund Manager- ICICI Securities
Stock Trading
Stock Markets Made Easy
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Renko Chart Patterns Made Easy
By — Kaushik Akiwatkar, Derivative Trader and Investor
Stock Trading
Market 101: An Insight into Trendlines and Momentum
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Mar
